Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
The Competition Council has authorised the transaction through which Pavăl Holding intends to acquire the Carrefour group in Romania.
Romanian construction company Concelex recorded revenues of RON 1.48 billion (€296 million) in 2025, representing a 17 per cent increase compared to the previous year.
Polytrade Global, a Romanian group specialising in energy infrastructure, the supply of electrical equipment, and renewable energy projects, closed 2025 with a turnover of around €21.5 million, a 173% increase on the previous year, and a net profit of €579,000.
Electrica announces the completion of the competitive procedure for the selection of an EPC Contractor and the signing, by its wholly owned subsidiary New Trend Energy, of the contract for the Satu Mare 3 photovoltaic project.
Christian Tour debuted on the BVB on 22 June, trading under the ticker symbol TRIP. The listing follows an IPO valued at RON 149 million (€28.4 million), with a 121% subscription rate. It is the first company from the organised tourism sector to debut on the local capital market.